News

Official statement on MS Society South Australia & Northern Territory voluntary administration

23 September 2025

We are deeply saddened to learn that MS Society South Australia & Northern Territory (MS SA&NT) has entered into voluntary administration.

Our immediate concerns are for people living with MS, families and carers who rely on the services provided by MS SA&NT, as well as the dedicated staff who have contributed so much to supporting people living with MS in our communities.

MS SA&NT is a separate Member Organisation, and its decision to move into voluntary administration does not affect MS Australia or the capacity of our other state Member Organisations to meet the needs of their clients, supporters and funders.

MS Australia will work closely with our MS Member Organisations, sector partners and government to assess the situation and determine how best to facilitate the continuation of services in South Australia and the Northern Territory. This decision has no impact on the operation of the other MS organisations.

Our priority is to ensure that people living with MS, their families and carers continue to have access to the care and support that is so important in daily life.

This situation highlights the urgent need for stronger, sustainable funding and policy settings so disability and health providers can remain viable and continue to deliver essential supports in our communities.

We will provide updates as soon as possible.

Related News

MS News

National Pain Week: We need better answers for pain in multiple sclerosis

28 July 2026

CEO Rohan Greenland calls on the Australian Government to significantly boost support for pain and neurological research this National Pain Week, explaining why pain experienced by people living with MS is under-recognised and, too often, inadequately treated.

MS News

How does AHSCT compare with other MS treatments?

28 July 2026

New research shows AHSCT was superior to cladribine and alemtuzumab in reducing relapses in people with relapsing remitting MS.

MS News

Ocrevus and Kesimpta & the Government’s rapid review of MS medications

22 July 2026

On Thursday 16 July, the Australian Government announced that Ocrevus and Kesimpta would remain on the Pharmaceutical Benefits Scheme (PBS).

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Official statement on MS Society South Australia & Northern Territory voluntary administration